EP1567506A4
Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
29 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29
Every citation, both waysCites: the store holds 2 of 3
| Document | Relation | Office | Cited during |
|---|---|---|---|
| CN108285421A | Cited by | China | Search report |
| EP1067123A1 | Cites | European Patent Office (EPO) | Examiner |
| EP1110953A1 | Cites | European Patent Office (EPO) | Examiner |
| No further relevant documents disclosed | Non-patent | – | Search report |
| See also references of WO 2004046101A2 | Non-patent | – | Examiner |
14 members in 7 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 427544P | United States of America | – | |
| 42754402 | United States of America | P | |
| 42754402 | United States of America | P | |
| 0335670 | United States of America | W | |
| 0335670 | United States of America | W | |
| 427544P | – | – | – |
| US20020427544P | – | – | – |
| US2003035670 | – | – | – |
| WO2003US35670 | – | – | – |
Members14
| Document | Office | Kind | |
|---|---|---|---|
| CA2506503A1 | Canada | A1 | |
| WO2004046101A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003291394A1 | Australia | A1 | |
| WO2004046101A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2005101617A1 | United States of America | A1 | |
| EP1567506A2 | European Patent Office (EPO) | A2 | |
| JP2006508979A | Japan | A | |
| EP1567506A4This record | European Patent Office (EPO) | A4 | |
| NZ540092A | New Zealand | A | |
| US2009012290A1 | United States of America | A1 | |
| US7488823B2 | United States of America | B2 | |
| AU2003291394B2 | Australia | B2 | |
| JP4611745B2 | Japan | B2 | |
| US8088766B2 | United States of America | B2 |
10 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Applications withdrawn, deemed to be withdrawn, or refused after publication in hong kongWithdrawnWD | WD | HK | |
| Application deemed to be withdrawnWithdrawn18D | 18D | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1567506
- Publication, DOCDB
- 1567506
- Publication, EPODOC
- EP1567506
- Application
- 3768789
- Application, DOCDB
- 03768789
- Application, EPODOC
- EP20030768789
Titles3
- German
- CYANOGUANIDINE UND CYANOAMIDINE ALS ERBB2- UND EGFR-INHIBITOREN
- English
- CYANOGUANIDINES AND CYANOAMIDINES AS ERBB2 AND EGFR INHIBITORS
- French
- CYANOGUANIDINES ET CYANOAMIDINES UTILISEES COMME INHIBITEURS DE ERBB2 ET EGFR
Classification
- CPC, 8
- C07D417/14
- C07D239/94
- C07D401/12
- C07D403/12
- C07D405/04
- A61P31/18
- A61P35/00
- A61P43/00
- IPC, 10
- A61P31 18
- A61P35 00
- C07D239 94
- C07D401 12
- C07D403 12
- C07D405 04
- C07D417 14
- C07D215 42
- A61K31 517
- A61K31 4706
Designated states2
- Contracting states, 1
- Türkiye
- Extension states, 1
- North Macedonia
